- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03772301
Evaluation of Hoarding Behaviour and Eating Disorders Among Holocaust Survivors and Their Descendants
December 10, 2018 updated by: Hillel Yaffe Medical Center
"Hoarding "is a common behavior among Holocaust survivors and is related to the traumatic events they have experienced, and we assume that storage behavior and eating disorders are related to future generations of Holocaust survivors.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
1000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Jewish Holocaust survivors living in Germany and Israel Their direct offspring and their children (second and third generation)
Description
Inclusion Criteria:
Jewish Holocaust survivors living in Germany and Israel who have expressed their written and written consent to participate in monitoring and testing, and who are able to answer the research questionnaires.
• Their direct offspring and their children (second and third generation)
- The control population - non-Jewish subjects who are not the descendants of Holocaust survivors living in Germany who have expressed their written and oral consent to participate in monitoring and testing and who are able to answer the research questionnaires and whose parents were not imprisoned in the camps second.
Exclusion Criteria:
- (Participants who do not agree to participate (did not sign informed consent form
- Respondents who are unable to answer interviewer questions
- Non-Jewish subjects whose parents were in camps (ie prisoner camps, labor camps, etc.) during the second war.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Group 1
At least 200 Jewish Holocaust survivors of the first generation living in Germany and Israel - an equal number in each country
|
Group 2
The second generation, whose parents lived in Europe during the Second World War, now live in Germany (originating from Western and Eastern Europe) - at least 200 participants.
|
Group 3
Third generation of Jewish Holocaust survivors who participated in the first phase, currently living in Germany and Israel - at least 200 participants including at least 100 subjects in each country.
These are adults only.
The research program does not include children and adolescents
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hoarding
Time Frame: Three years
|
Questionnaire that will follow behaviour over generations
|
Three years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2019
Primary Completion (Anticipated)
January 1, 2022
Study Completion (Anticipated)
January 1, 2022
Study Registration Dates
First Submitted
December 10, 2018
First Submitted That Met QC Criteria
December 10, 2018
First Posted (Actual)
December 11, 2018
Study Record Updates
Last Update Posted (Actual)
December 11, 2018
Last Update Submitted That Met QC Criteria
December 10, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HYMC-0083-18
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hoarding Disorder
-
Hartford HospitalNeuroneticsCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH)Active, not recruitingHoarding Disorder | Hoarding | ClutterUnited States
-
Stanford UniversityNational Institute on Aging (NIA)CompletedHoarding Disorder | Hoarding | ClutterUnited States
-
University of California, San DiegoRecruitingDepression | Hoarding Disorder | HoardingUnited States
-
Mississippi State UniversityNational Institute of Mental Health (NIMH)RecruitingHoarding DisorderUnited States
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemRecruitingHoarding DisorderUnited States
-
Florida State UniversityCompleted
-
New York State Psychiatric InstituteHartford HospitalCompleted
-
New York State Psychiatric InstituteCompleted
-
Karolinska InstitutetCompletedHoarding DisorderSweden